Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

Rectal Cancer Clinical Trial

Official title:

Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01003600
• Other study ID #: 09-133
• Status: Completed
• Phase: N/A
• First received: October 28, 2009
• Last updated: November 26, 2014
• Start date: October 2009
• Est. completion date: November 2014

Study information

• Verified date: November 2014
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

We are doing this study to learn more about colon and rectal cancer survivors. We want to know if survivors want more information about life after cancer. Do cancer survivors want to know more about their own cancer? Do cancer survivors want to know about their treatment? Do cancer survivors want to know what health care they should get in the future? We want to know what information to give to cancer survivors when they finish treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 177
• Est. completion date: November 2014
• Est. primary completion date: November 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older at diagnosis

• Diagnosed with first primary colorectal cancer (stage I-III)

• Completed last treatment for colorectal cancer (surgery, chemotherapy, or radiation) at least 6 months and no more than 2 years before the date of study enrollment

• Able to speak English, because questionnaire is only available in English

• Able to provide informed consent

• Received all treatment for colorectal cancer at MSKCC or QCC or, surgical treatment at an outside facility, and all other treatment (chemotherapy or radiation) at MSKCC or QCC

Exclusion Criteria:

• Undergoing active treatment for colorectal cancer

• Diagnosed with metastatic colorectal cancer

• Prior history of colorectal or any other cancer (except non-melanoma skin cancer)

• Diagnosed with new or recurrent colorectal or other cancer after the primary colorectal cancer diagnosis

• Received a survivorship care plan from the treating institution

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Colon Cancer
• Colorectal Neoplasms
• Rectal Cancer

Intervention

Behavioral:
• Questionnaire
The questionnaire will be administered by telephone and will take approximately 20-30 minutes. The questionnaire will elicit survivor responses along five domains: knowledge about diagnosis and treatment, knowledge about ongoing risks and recommended testing, history of health care utilization since the end of treatment, preferences for relevant information about these topics, and employment after the end of cancer treatment.

Locations

Country	Name	City	State
United States	Queens Cancer Center of Queens Hospital	Jamaica	New York
United States	Memorial Sloan-Kettering Cancer Center	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Queens Cancer Center of Queens Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess colorectal cancer survivors' basic knowledge of their own cancer history, including date of diagnosis, stage, and treatments received.		6 months to 2 years after completion of treatment	No
Secondary	Assess survivors' knowledge of medical issues relevant to colorectal cancer survivors.		6 months to 2 years after completion of treatment	No
Secondary	Describe the types of health care providers that survivors have visited since completing treatment for colorectal cancer.		6 months to 2 years after completion of treatment	No
Secondary	Assess survivors' preferences for the content, format, and delivery of survivorship care plans.		6 months to 2 years after completion of treatment	No
Secondary	Assess whether survivors who had concerns about working after cancer treatment spoke with health care professionals about their concerns.		6 months to 2 years after completion of treatment	No

External Links

•   Memorial Sloan-Kettering Cancer Center